Evidence map›Paper›PMID 32939095›Full record

ArticleNature immunology2020

Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.

Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Moore, Zhenhua Ren, Changzheng Lu, Xuezhi Cao and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Chuanhui Han *Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Zhida Liu *Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Yunjia ZhangDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Aijun ShenDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Chunbo DongDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Anli ZhangDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7847-6541
Casey MooreDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7135-8016
Zhenhua RenDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2560-5618
Changzheng LuDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Xuezhi CaoDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Chun-Li ZhangDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Jian QiaoDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. Jian.Qiao@UTSouthwestern.edu.ORCID http://orcid.org/0000-0002-5228-2906
Yang-Xin FuDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. Yang-Xin.Fu@UTSouthwestern.edu.ORCID http://orcid.org/0000-0002-4809-825X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.